They’re putting the “men” in menstruation. Recently, several dudes have taken to TikTok proclaiming that a man can start a woman’s period just by lowering the register of his voice. “You’ve never made ...

Have you ever heard two or more women say they're on the same cycle? This is a common claim among women who live together, for example in a family or as housemates. This idea that people menstruate, ...

Having your period can be a painful experience. Period pain, also known as dysmenorrhea, is a very common condition with around nine in ten young women aged 13 to 25 in Australia having regular period ...

Getting your first period can come with a lot of conflicting feelings, from confusion and fear to excitement or relief. Knowing what to expect — as much as is possible — is one thing that can make ...

In the first of Cyclingnews' women's health series, as health-tracking technology becomes ever-present in cycling, how are female cyclists using it to monitor their health, and is all this data ...

Serrano is a contributor for TIME. Serrano is a contributor for TIME. Imagine there was something you could do that would not only improve your mood, cognition, and energy, but also lower your chances ...

While period pain and heavy menstrual bleeding are common, they’re often dealt with privately. Yet they take a profound toll on a person’s health – and finances. Now, our new study has calculated how ...

The fatal shooting of a Minneapolis woman in her car by an Immigration and Customs Enforcement officer Jan. 7 brought more scrutiny on Trump-era training requirements. On CNN’s “State of the Union” ...

After a brief holiday break, Barcelona have resumed training as they prepare for the second half of the season. Barcelona’s 2026, after all, will start with an away game against Catalan rivals ...

The idea that we should make lifestyle adjustments depending on where we are in our menstrual cycle is gaining traction online, as well as in scientific circles. Now, researchers have found that ...

In a phase 1–2 trial, teclistamab, a bispecific antibody targeting CD3 on T-cell surfaces and B-cell maturation antigen on myeloma cells, showed durable responses in heavily pretreated patients with ...